THE HAGUE, April 10 (NNN-AGENCIES) — The EU’s drug regulator said it had launched a review of possible links between the Johnson & Johnson coronavirus vaccine and blood clots after reports of four cases, one of them fatal.
The European Medicines Agency (EMA) said its safety committee “has started a review of a safety signal to assess reports of thromboembolic events” with people who had received the shot.
Three of the cases were seen in the United States after the jab was rolled out there and one was during clinical trials in an undisclosed location, the EMA said. The EU has authorised the jab but not started using it.
Meanwhile, the WHO said in GENEVA there was “no adequate data” on switching Covid-19 vaccines between doses, as France said under-55s who received an AstraZeneca first jab should get their second from a different vaccine.
“There is no adequate data to be able to say whether this is something that could be done, so… interchangeability of vaccine was not something that we could give a recommendation on,” World Health Organization spokeswoman Margaret Harris told reporters. — NNN-AGENCIES– NNN-AGENCIES
